267 - Virus on the Brain: Pathogenesis of Neurovirulent Viral Infections

Saturday, October 19, 2024

3:15 PM – 4:30 PM US PT

Location: 515 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Christine Johnston, MD, MPH (she/her/hers)

Associate Professor
Medicine
University of Washington
Seattle, WA, United States
David Dobrzynski, Jr., MD

Assistant Professor of Medicine, Program Director Infectious Diseases Fellowship, Medical Director Antimicrobial Stewardship Program
Infectious Diseases
University of Rochester Medical Center
Rochester, NY, United States

Faculty(s)

Lisa Akhtar, MD, PhD (she/her/hers)

Assistant Professor
Department of Pediatrics
Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago
CHICAGO, IL, United States
Michael Wilson, MD, MAS (he/him/his)

Professor
UCSF
San Francisco, CA, United States
IC

Irene Cortese, MD

Investigator
National Institutes of Health

Disclosure(s):

Christine Johnston, MD, MPH: Assembly Bioscience: Advisor/Consultant (Ongoing); Gilead Biosciences: Grant/Research Support (Terminated, December 31, 2022); GSK: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Moderna, Inc.: Grant/Research Support (Ongoing); Pfizer, Inc.: Advisor/Consultant (Ongoing)

David Dobrzynski, MD, Jr.: DYNAMED (https://www.dynamed.com/): Advisor/Consultant (Ongoing); Innoviva Specialty Therapeutics, Inc.: Advisor/Consultant (Terminated, December 29, 2023)

Lisa N. Akhtar, MD, PhD: No financial relationships to disclose

Michael R. Wilson, MD, MAS: No financial relationships to disclose

Irene Cortese, MD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe how hsv host-pathogen interactions in the cns contribute to hsv encephalitis in neonatal and adult populations;
recognize the mechanisms of neuroinflammation induced by sars-cov-2 that contribute to symptoms of long covid;
identify risk factors for and treatment of pml with currently available immunosuppressive agents.

Presentations:

3:15 PM – 3:40 PM US PT

HSV Encephalitis and Neuropathogenesis of HSV infection
Speaker: Lisa N. Akhtar, MD, PhD (she/her/hers) – Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago
3:40 PM – 4:05 PM US PT

SARS-CoV-2 and Neuroimmunology
Speaker: Michael R. Wilson, MD, MAS (he/him/his) – UCSF
4:05 PM – 4:30 PM US PT

PML: Pathogenesis and risks in the current era of immunosuppression
Speaker: Irene Cortese, MD – National Institutes of Health